ATM and renal carcinoma: Mechanistically, these results suggest that the combined inhibition of CK2 and ATM in renal cancer cells triggers an HIF-2α/NOX4-dependent ROS overproduction, leading to cellular damages and ultimately to Caspase-mediated irreversible cell death (Figure 6).